Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine episode artwork

EPISODE · Aug 19, 2026 · 1 MIN

Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine

from Minute Briefing · host The Wall Street Journal

Plus: Target’s second-quarter sales suggest the retailer’s turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi’s prediction markets. Alex Ossola hosts. Sign up for WSJ’s free What’s News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Episode metadata supplied by the publisher feed · Published Aug 19, 2026

Embed this episode

Ready to play

Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine

0:00 1:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Minute Briefing?

This episode is 1 minute long.

When was this Minute Briefing episode published?

This episode was published on August 19, 2026.

Can I download this Minute Briefing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!